Litigation Details for Novartis Pharmaceuticals Corporation v. Ranbaxy Inc. (D. Del. 2014)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2014-12-28
Court	District Court, D. Delaware	Date Terminated	2015-10-21
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	NOVARTIS AG
Patents	6,894,051; RE43,932
Attorneys	Michael P. Kelly
Firms	UNDELIVERABLE EMAIL 11/9/2021, Schiff Hardin LLP
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2014-12-28	1		THE PATENTS IN SUIT 17. United States Patent No. 6,894,051 (the “’051 Patent”) duly …the ’051 Patent. 19. United States Reissue Patent No. RE43,932 (the “RE932 Patent”) duly …of the ’051 Patent and the RE932 Patent, would constitute infringement of the ’051 Patent and the RE932…date on which last-expiring patent of the ’051 Patent and the RE932 Patent expires, including any associated… This is an action for patent infringement arising under the patent laws of the United States,	External link to document
2015-10-21	23		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051; RE43,932. (ntl) (Entered…2014 21 October 2015 1:14-cv-01526 830 Patent None District Court, D. Delaware	External link to document
2014-12-28	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051; RE43,932;. (dmp, )…2014 21 October 2015 1:14-cv-01526 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document